ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
DemeRx Receives MHRA Approval for DMX-1002 Study for Opioid Use Disorder americanpharmaceuticalreview
March 17, 2021DemeRx IB, an atai Life Sciences (atai) platform company focused on developing ibogaine for the treatment of opioid use disorder (OUD), announced the company has approval from the UK Medicines and Healthcare products Regulatory Agency (MHRA) to ...
Pharma Sources Insight January 2025
